No established definition exists of therapeutic success after high-intensity focused ultrasound in patients with localized prostate cancer. A recent analysis has proposed a definition of biochemical failure for use in this setting. However, much work still needs to be done on identifying suitable predictors of clinical failure, and large-scale validation is certainly required.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Chavrier, F. et al. Modeling of HIFU induced lesions in the presence of cavitation bubbles. J. Acoust. Soc. Am. 108, 432–440 (2000).
Poissonnier, L. et al. Control of prostate cancer by transrectal HIFU in 227 patients. Eur. Urol. 51, 381–387 (2007).
Gelet, A. et al. Transrectal high intensity focused ultrasound for the treatment of localised prostate cancer: factors influencing the outcome. Eur. Urol. 40, 124–129 (2001).
Thüroff, S. et al. High intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study. J. Endourol. 17, 673–677 (2003).
Chaussy, C. & Thüroff, S. The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection. Curr. Urol. Rep. 4, 248–252 (2003).
Blana, A. et al. Eight years' experience with high-intensity focused ultrasonography for treatment of localized prostate cancer. Urology 72, 1329–1333 (2008).
Ganzer, R. et al. PSA nadir is a significant predictor of treatment failure after high-intensity focused ultrasound (HIFU) treatment of localised prostate cancer. Eur. Urol. 53, 547–553 (2008).
Blana, A. et al. High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure. BJU Int. 104, 1058–1062 (2009).
Roach, M. III et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int. J. Radiat. Oncol. Biol. Phys. 65, 965–974 (2006).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
A. Pollack has received honoraria from General Electric for participating in a speakers bureau. M. Abdel-Wahab declares no competing interests.
Rights and permissions
About this article
Cite this article
Abdel-Wahab, M., Pollack, A. Defining biochemical failure in patients treated with HIFU. Nat Rev Urol 7, 186–187 (2010). https://doi.org/10.1038/nrurol.2010.12
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2010.12
